Responses
Clinical/translational cancer immunotherapy
Original research
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.